A crystalline hydrated form of the compound bis(e)-7-[4-(4-flourophenyl) 6-isopropyl-2 [methyl(methylsulfonyl)amino] pyrimidin-5-yl](3r,5s)-3,5 dihydroxyhept-6-enoic acid]calcium salt
PK140853AUndetermined Publication Date: 2010-08-11ASTRAZENECA AB
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200400673
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-08-11
Abstract
Two polymorphic form of bis[(E)-7-[4 (4-flourophenyl)-6-isopropyl-2 [methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3 ,5-dihydroxyhept-6 enoic acid] calcium salt and their use as HMG Co-A reductase inhibitors are described.
Need to check novelty before this filing date? Find Prior Art